Sign in to view content

A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD

Vrinda S. Hershberger, MD, PhD

Video
Published 2021

Related

Clinical Utility of the Fellow Eye in Patients With Bilateral GA Due to AMD: Long-Term Data from the Pegcetacoplan Clinical Program
Diana V Do, MD, FASRS
Updates from the Field
2025
Silicone Oil Large and Small Droplets 8 Days Post Avastin (Avella) Injection
Paul E. Tornambe, MD
Lon S. Poliner, MD
Retina Image Bank: Images of the Week
2016
VERONA: End-of-Study Results From a Phase 2 Trial of EYP-1901 (Vorolanib Intravitreal Insert) vs Afliberceptfor Diabetic Macular Edema
Yasha S Modi, MD
Annual Meeting Talks
2025

Category: AMD-Neovascular

See more